PT Ethica Industri Farmasi, which is a pharmaceutical company under the auspices of PYFAGROUP, has officially carried out groundbreaking expansion of injection production facilities in the Cikarang industrial area, Bekasi Regency, West Java, on Monday (9/9).
With significant investment, Ethica Pharmaceutical Industry is committed to increasing production capacity by three times.
This facility expansion is equipped and designed with advanced and modern production technology, meeting… standar current Good Manufacturing Practices (cGMP) Indonesia and international, PIC/S, including requirements European Union Good Manufacturing Practices (EU GMP) and Therapeutic Goods Administration (TGA) Australia.
This shows Ethica Pharmaceutical Industry’s readiness to penetrate a wider global market.
“The increasing demand for injection products is the main motivation for us to expand to meet the demand from hospitals that have grown rapidly in recent years,” said President Director of PT Ethica Industri Farmasi, Merciana Evy, quoted from a statement received on Thursday (12/9).
As part of the big PYFAGROUP family, Evy emphasized that PT Ethica Industri Farmasi continues to be committed to innovating and making greater contributions to the Indonesian pharmaceutical industry.
“With increased production capacity, we are ready to meet the need for high-quality medicines, both in the domestic and international markets,” he added.
With this expansion, Ethica Industri Farmasi further strengthens its position as one of the leading pharmaceutical companies in Indonesia. The company is ready to become a major player in the global pharmaceutical industry, focusing on the development and production of innovative medicines. (J-3)
#Expanding #Production #Facilities #Domestic #Pharmaceutical #Industry #Ready #Explore #Global #Market
What are the key factors driving the expansion of PT Ethica Industri Farmasi’s production facilities?
Table of Contents
Title: “Enhancing Production Capacity: Ethica Pharmaceutical Industry Expands Facilities to Tap Global Market”
Meta Description: Discover how PT Ethica Industri Farmasi, a prominent pharmaceutical company, is expanding its production facilities to meet increasing demand and pursue a larger share of the global market.
Keywords: Ethica Pharmaceutical Industry, production facilities, injection production, cGMP, EU GMP, TGA, global market, pharmaceutical industry, Indonesia.
Introduction:
The Indonesian pharmaceutical industry is witnessing significant growth, driven by the increasing demand for quality healthcare products. To capitalize on this trend, PT Ethica Industri Farmasi, a leading pharmaceutical company under the umbrella of PYFAGROUP, has embarked on an ambitious project to expand its injection production facilities in Cikarang, Bekasi Regency, West Java. This strategic move aims to triple the company’s production capacity, paving the way for it to explore the global market.
The Need for Expansion:
The growing demand for injection products has prompted Ethica Pharmaceutical Industry to invest significantly in its production facilities. The company’s President Director, Merciana Evy, attributed the rapid expansion to the increasing orders from hospitals in recent years. By augmenting its production capacity, Ethica Pharmaceutical Industry aims to not only meet the surging domestic demand but also to establish a stronger foothold in the global pharmaceutical market.
Advanced Technology and Compliance:
The expanded facilities are designed and equipped with state-of-the-art production technology, ensuring compliance with current Good Manufacturing Practices (cGMP) in Indonesia and internationally recognized standards, such as the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S), European Union Good Manufacturing Practices (EU GMP), and Therapeutic Goods Administration (TGA) Australia. This commitment to quality and regulatory compliance demonstrates Ethica Pharmaceutical Industry’s readiness to cater to the global market.
Global Ambitions:
Ethica Pharmaceutical Industry’s expansion plan is a testament to its commitment to innovation and growth. As a part of the PYFAGROUP family, the company is poised to tap into the global market, leveraging its enhanced production capacity and expertise to provide high-quality pharmaceutical products to a wider audience.
Conclusion:
The expansion of Ethica Pharmaceutical Industry’s production facilities is a significant milestone in the company’s history, underscoring its determination to become a leading pharmaceutical player in Indonesia and beyond. With its sights set on the global market, the company is well-positioned to capitalize on the growing demand for quality healthcare products, ultimately contributing to the improvement of healthcare outcomes worldwide.
Image Optimization:
Figure caption: “Injection production facilities. (MI/Naufal Zuhdi)”
Image description: “A photo of an injection production facility, highlighting the advanced technology and modern equipment used in the production process.”
Image alt text: “Injection Production Facilities, PT Ethica Industri Farmasi”
Header Tags:
H1: Enhancing Production Capacity: Ethica Pharmaceutical Industry Expands Facilities to Tap Global Market
H2: The Need for Expansion
H2: Advanced Technology and Compliance
H2: Global Ambitions
H2: Conclusion
Internal and External Linking:
Link to relevant articles on the pharmaceutical industry, global market trends, and regulatory compliance.
Provide internal links to other articles on the company’s history, products, and services.
By optimizing this article with relevant keywords, meta tags, and header tags, we can improve its visibility on search engines and attract more readers interested in the pharmaceutical industry and global market trends.
What are the benefits of PT Ethica Industri Farmasi expanding its production facilities?
Here is a comprehensive and SEO-optimized article on the topic of PT Ethica Industri Farmasi’s expansion of its production facilities:
Enhancing Production Capacity: Ethica Pharmaceutical Industry Expands Facilities to Tap Global Market
The Indonesian pharmaceutical industry is witnessing significant growth, driven by the increasing demand for quality healthcare products. To capitalize on this trend, PT Ethica Industri Farmasi, a leading pharmaceutical company under the umbrella of PYFAGROUP, has embarked on an ambitious project to expand its injection production facilities in Cikarang, Bekasi Regency, West Java. This strategic move aims to triple the company’s production capacity, paving the way for it to explore the global market.
The Need for Expansion
The growing demand for injection products has prompted Ethica Pharmaceutical Industry to invest significantly in its production facilities. The company’s President Director, Merciana Evy, attributed the rapid expansion to the increasing orders from hospitals in recent years. By augmenting its production capacity, Ethica Pharmaceutical Industry aims to not only meet the surging domestic demand but also to establish a stronger foothold in the global pharmaceutical market.
Advanced Technology and Compliance
The expanded facilities are designed and equipped with state-of-the-art production technology
